<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-title>BMC Cancer</journal-title>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16800899</article-id>
      <article-id pub-id-type="pmc">1523362</article-id>
      <article-id pub-id-type="publisher-id">1471-2407-6-169</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2407-6-169</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Ferrandina</surname>
            <given-names>Gabriella</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>gabriella.ferrandina@libero.it</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Salutari</surname>
            <given-names>Vanda</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>vsalutari@libero.it</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Testa</surname>
            <given-names>Antonia</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>atesta@rm.unicatt.it</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Zannoni</surname>
            <given-names>Gian Franco</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>gfzannoni@rm.unicatt.it</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Petrillo</surname>
            <given-names>Marco</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>marco.petrillo@virgilio.it</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Scambia</surname>
            <given-names>Giovanni</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>gscambia@rm.unicatt.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Gynecologic Oncology Unit, Catholic University, L.go Gemelli 8, 00168, Rome, Italy</aff>
      <aff id="I2"><label>2</label>Institute of Human Pathology, Catholic University, L.go Gemelli 8, 00168, Rome, Italy</aff>
      <aff id="I3"><label>3</label>Department of Oncology, Catholic University, Contrada Tappino, Campobasso, Italy</aff>
      <pub-date pub-type="collection">
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>6</month>
        <year>2006</year>
      </pub-date>
      <volume>6</volume>
      <fpage>169</fpage>
      <lpage>169</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/169"/>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>4</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>6</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 Ferrandina et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2006</copyright-year>
        <copyright-holder>Ferrandina et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Ferrandina
               Gabriella
               
               
               gabriella.ferrandina@libero.it
            </dc:author><dc:title>
            Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Cancer 6(1): 169-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2407(2006)6:1&#x0003c;169&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2407</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The occurrence of skeletal muscle metastases is a very rare event. Only two cases of late skeletal muscle recurrence from cervical cancer have been documented until now.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 38-year old patient, submitted to radical hysterectomy and pelvic lymphadenectomy for a squamous FIGO stage IB1 cervical carcinoma, presented after 76 months with a palpable, and painless swelling on the left hemithorax. MRI showed a nodule located in the context of the intercostal muscles. Pathology revealed the presence of metastasis of squamous cell carcinoma of similar morphology as the primary. On the basis of FDG-PET findings, which excluded other sites of disease, surgical excision of the lesion was performed. The patient was triaged to chemotherapy plus external radiotherapy.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>A case of skeletal muscle recurrence from cervical cancer after a very long interval from primary diagnosis is reported. Muscular pain or weakness, or just a palpable mass in a patient with a history of cancer has always to raise the suspicion of muscle metastasis.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The incidence of skeletal muscle metastases is reported to be less than 1% of metastases of haematogenous origin, despite the fact that skeletal muscle accounts for nearly 50% of the total body weight and is characterized by a rich blood supply [<xref ref-type="bibr" rid="B1">1</xref>]. The reasons for the rarity of metastatic involvement of skeletal muscle are still unclear, but several hypotheses have been made including: a) the constant movement of skeletal muscles, which may represent a difficult condition for the implantation and growth of metastatic cells under the high tissue pressure related to the exercise associated increase of blood flow; b) the local production of lactic acid, which would create an unfavourable environment for metastatic cell growth; c) the inhibition of cell invasion by protease inhibitors located in the basement membrane; d) the antitumor activity of lymphocytes and/or natural killer cells within the skeletal muscle; e) in vivo evidences that skeletal muscle-delivered peptidic factors may influence the metastatization process [<xref ref-type="bibr" rid="B1">1</xref>]. Psoas, iliopsoas and paraspinal muscles, and proximal musculature of the upper and lower limbs, represent the most frequently involved sites. Malignancies known to frequently metastasize to the muscle are melanoma, kidney, lung, thyroid cancer; moreover skeletal muscle metastases have been also reported in lymphoma, leukaemia and colon cancer patients [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>To our knowledge, five cases of skeletal muscle metastasis and two cases of skeletal muscle recurrence after 24 and 60 months fro initial diagnosis of cervical cancer have been documented until now [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>We report an unusual case of isolated intercostal muscle recurrence after a very long interval from primary diagnosis of squamous cervical cancer. A review of the literature with particular emphasis on the diagnostic and therapeutic issues is also presented.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 38-year old patient was admitted to the Gynaecologic Oncology Unit of the Catholic University of Rome in June 1998 for irregular vaginal bleeding. Gynaecological examination revealed an ulcerated lesion (maximum diameter = 3 cm) of the uterine cervix The histopathologic diagnosis of colposcopy-guided biopsy revealed the presence of moderately differentiated squamous cell cervical carcinoma. The patient was clinically staged as having FIGO stage IB1 cervical cancer and was submitted to radical hysterectomy and pelvic lymphadenectomy. Final staging was pT1bN0M0 according to TNM classification.</p>
      <p>After 76 months from initial diagnosis, the patient presented with a palpable, painless, mobile and tender swelling on the left side of the thorax approximately at the level of the 5th rib. Ultrasonography was performed revealing a subfascial hypoechogenic lesion (maximum diameter = 2 cm) within the intercostal muscles, close to the rib, which however, appeared uninvolved (Figure <xref ref-type="fig" rid="F1">1A</xref>). Magnetic Resonance Imaging (MRI) study of the left rib cage confirmed the presence of an intermediate intensity signal area in both T1 and T2-weighted images, with a moderate gadolinium-contrast enhancement, which was considered consistent with a desmoid lesion (Figure <xref ref-type="fig" rid="F1">1B</xref>). Gynecological examination as well as chest X-ray and MRI of the abdomen and pelvis were normal, and circulating levels of SCC were negative (0.8 ng/ml). Fine-needle aspiration of the lesion was planned and revealed the presence of squamous carcinoma cells. The patient was then investigated by fluorodeoxyglucose positron emission tomography (FDG-PET), which showed only two abnormal uptakes of the radiotracer in the left hemithorax (Figure <xref ref-type="fig" rid="F1">1C</xref>). On the basis of FDG-PET findings, which excluded other sites of metastatic disease, a wide surgical excision of the lesion was performed and final pathology revealed the presence of a nodule (maximum diameter = 1.7 cm) consistent with metastasis of squamous cell carcinoma (Figure <xref ref-type="fig" rid="F1">1D</xref>) of similar morphology as the primary. The surgical margins were free of disease.</p>
      <p>After extensive counselling, the patient was triaged to combined chemotherapy with carboplatin (5AUC) and paclitaxel (175 mg/m2), plus external radiotherapy (total dose = 4,000 cGy in 20 fractions) on the left hemi thorax. After two months from the completion of treatment, the patient shows no evidence of disease and does not complain of any symptom related to radiation treatment.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>We first reported a case of isolated intercostal cage muscle recurrence after a very long interval from the diagnosis of squamous cell carcinoma of the uterine cervix. As shown in Table <xref ref-type="table" rid="T1">1</xref>, skeletal muscle involvement from cervical carcinoma is very rare, and usually documented in the context of an already far advanced stage tumor or metastatic disease [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>], or in severely immunocompromised patients, as occurs in patients with AIDS [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. In addition, an unusual case of involvement of masseter muscle has been also described in a case with very aggressive histology [<xref ref-type="bibr" rid="B5">5</xref>]. Although the association between specific tumor histotypes and tendency to involve skeletal muscle has been not determined, in lung cancer skeletal muscle metastasis have been documented to more frequently develop from adenosquamous cell carcinoma [<xref ref-type="bibr" rid="B10">10</xref>]. The clinical outcome of patients with skeletal muscle metastasis is generally poor [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B10">10</xref>], given the common finding of diffuse metastatic disease. As shown in Table <xref ref-type="table" rid="T1">1</xref>, most of the data about the clinical course of cervical cancer patients with skeletal muscle involvement is lacking.</p>
      <p>Establishing the diagnosis of skeletal muscle metastasis sometimes can be difficult: indeed, although skeletal muscle metastases can be painful or palpable or cause deformity according to location, sometimes they can be asymptomatic. Indeed, our patient only complained of a mobile, painless swelling, which could have been easily underestimated given the long interval from initial diagnosis, the favourable clinical pathological characteristics of disease (squamous histotype, FIGO stage IB1), and, above all, the unusual and unexpected recurrence presentation. Although the histopathological evaluation represents a more straight forward diagnostic approach, diagnostic imaging techniques are useful tools in order to define the site and extension of disease [<xref ref-type="bibr" rid="B11">11</xref>], and exclude diffuse metastases. However, the differential diagnosis between primary intramuscular tumor and metastasis, which is a very important issue for patient prognosis and clinical management, is not easy: in our case MRI showed an intermediate signal area intensity on T1 and T2-weighted scans, very similar to the muscle tissue but with an important enhancement after the contrast injection. None of the diagnostic tools used documented any signs of the presence of necrosis or haemorrhage. which would have been suggestive of a pattern of rapid growth. In this context, much attention has been focused on the usefulness of FDG-PET not only for staging, but also for the detection of recurrence in cervical carcinoma: in our case FDG-PET findings showed to be critical in order to plan patient management since a diffuse metastatic disease was excluded, and surgical removal of the intercostal muscle recurrence could be planned. Given the very rare occurrence of skeletal muscle metastasis, there are no specific guidelines on the therapeutic options, which include radiotherapy, chemotherapy and surgery according to the clinical setting: indeed, the real benefit of these approaches remains questionable given the very poor prognosis of these patients. As shown in Table <xref ref-type="table" rid="T1">1</xref>, in case of a solitary and surgically resectable skeletal muscle metastasis, metastasectomy has been performed, followed by radiotherapy [<xref ref-type="bibr" rid="B9">9</xref>]. In our case the choice of a multimodal approach was sustained by i)the young age of the patient and her good performance status; i) the documentation of a single and surgically amenable recurrence; ii) the general consideration of skeletal muscle metastasis as a marker of systemic disease, which would require chemotherapy: in particular the platinum-taxane combination was chosen on the basis of the high response rate documented with this regimen with respect to cisplatin alone [<xref ref-type="bibr" rid="B12">12</xref>]; the choice of using carboplatin instead of cisplatin was motivated by the documentation of a better patient convenience and tolerance together with the encouraging results obtained with carboplatin/paclitaxel regimen in advanced/recurrent pre-irradiated cervical cancer patients [<xref ref-type="bibr" rid="B13">13</xref>]. In addition, radiotherapy was planned in order to achieve a better local control of disease, after balancing and discussing with the patient the overall risk of pulmonary fibrosis related to the specific site of irradiation.</p>
      <p>In conclusion, we reported a case of a solitary distant skeletal muscle recurrence from early stage cervical cancer after a very long interval from primary diagnosis. Late recurrence (i.e. after a disease-free interval of more than 5 years) in cervical cancer patients is considered a very rare event occurring in approximately 4% of cases with a frequency increasing from 1.8% in stage I, to 5.2% and 8.5% in stage II and III disease, respectively [<xref ref-type="bibr" rid="B14">14</xref>]. These figures suggest that cervical cancer patients, especially those bearing stage II-III disease warrant long follow up care, because of the long period of tumor cell dormancy. In particular, muscular pain or weakness, or just a palpable mass in a patient with a history of cervical cancer has always to raise the suspicion of metastatic muscular disease.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>GF conceived the study, was the coordinator of the study, and drafted the manuscript</p>
      <p>VS collected the clinical data</p>
      <p>AT was responsible for the clinical surveillance</p>
      <p>GFZ was responsible for the evaluation of histopathological data</p>
      <p>MP participated in the coordination of the study, and in drafting the manuscript</p>
      <p>GS participated in the draft of the study, and in the conception of the study</p>
      <p>All authors read and approved the final manuscript</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/169/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This work was financially supported by grants from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C) and I.R.I.S-PCR-OG-ONLUS <ext-link ext-link-type="uri" xlink:href="http://www.iris-og.com"/>.</p>
        <p>Written consent was obtained from the patient for publication of the study.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sudo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ogihara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiokawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujinami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sekiguchi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Intramuscular metastasis of carcinoma</article-title>
          <source>Clin Orthoped</source>
          <year>1993</year>
          <volume>296</volume>
          <fpage>213</fpage>
          <lpage>217</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mariya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tarusawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takekawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kattou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kaimori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ise</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Metastasis of uterine cervix to the biceps muscle of right upper arm: report of a case</article-title>
          <source>Rinsho-Hoshasen</source>
          <year>1990</year>
          <volume>35</volume>
          <fpage>1447</fpage>
          <lpage>1450</lpage>
          <pub-id pub-id-type="pmid">2277431</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Carcangiu</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Braham</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion</article-title>
          <source>Gynecol Oncol</source>
          <year>1991</year>
          <volume>41</volume>
          <fpage>255</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">1869105</pub-id>
          <pub-id pub-id-type="doi">10.1016/0090-8258(91)90319-Z</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Aikins</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Deger</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mikuta</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Metastatic cervical cancer and pelvic inflammatory disease in an AIDS patient</article-title>
          <source>Gynecol Oncol</source>
          <year>1994</year>
          <volume>54</volume>
          <fpage>372</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">8088616</pub-id>
          <pub-id pub-id-type="doi">10.1006/gyno.1994.1226</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Passy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>DiSaia</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Metastatic small cell carcinoma to the masseter muscle originating from the uterine cervix</article-title>
          <source>Ear Nose Throat</source>
          <year>1995</year>
          <volume>74</volume>
          <fpage>118</fpage>
          <lpage>121</lpage>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar-Dayan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rachmani</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Squamous cell carcinoma of the cervix with psoas abscess-like metastasis in an HIV-negative patient</article-title>
          <source>Isr J Med Sci</source>
          <year>1997</year>
          <volume>33</volume>
          <fpage>674</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">9397142</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pathy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jayalakshmi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chander</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thulkar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma cervix with metastases to deltoid muscle</article-title>
          <source>Clin Oncol</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>447</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="doi">10.1053/clon.2002.0106</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devendra</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tay</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Metastatic carcinoma of the cervix presenting as a psoas abscess in an HIV-negative woman</article-title>
          <source>Singapore Med J</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>302</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="pmid">14560863</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saadi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hadadi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Amauoi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Errihani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mansouri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Benjaafar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>El Gueddari</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <article-title>M&#xE8;tastase musculaire d'un carcinoma &#xE8;pidermoide du col &#xF9;terin</article-title>
          <source>Cancer Radiotherapie</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>187</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">12834775</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsunezuka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A case of adenosquamous cell carcinoma of the lung which was found by metastasis to the skeletal muscle</article-title>
          <source>Jpn J Lung Cancer</source>
          <year>1994</year>
          <volume>34</volume>
          <fpage>411</fpage>
          <lpage>416</lpage>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damron</surname>
              <given-names>Ta</given-names>
            </name>
            <name>
              <surname>Heniner</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature</article-title>
          <source>Ann Surg Oncol</source>
          <year>2000</year>
          <volume>7</volume>
          <fpage>526</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="pmid">10947022</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10434-000-0526-7</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Blessing</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>McQuellon</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Thaler</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Cella</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Benda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Olt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boggess</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Rocereto</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>Phase III study of cisplatin with or without paclitaxel in stage IV B, recurrent or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>3113</fpage>
          <lpage>3119</lpage>
          <pub-id pub-id-type="pmid">15284262</pub-id>
          <pub-id pub-id-type="doi">10.1200/JCO.2004.04.170</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tinker</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bhagat</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Swenerton</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Hoskins</surname>
              <given-names>PJT</given-names>
            </name>
          </person-group>
          <article-title>Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience</article-title>
          <source>Gynecol Oncol</source>
          <year>2005</year>
          <volume>98</volume>
          <fpage>54</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">15904950</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ygyno.2005.03.037</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takehara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shigemasa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sawasaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Naito</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Recurrence of invasive cervical carcinoma more than 5 years after initial therapy</article-title>
          <source>Obstet Gynecol</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>680</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="pmid">11576588</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0029-7844(01)01501-0</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figures and Tables</title>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p><bold>A</bold>. Ultrasonography of the left thorax documenting a hypoechogenic nodule in the context of the intercostal muscle, close to the underlying rib. The nodule shows intralesional vessels at Color Doppler examination. <bold>B</bold>. T1-weighted MRI showing the presence of a moderate gadolinium-contrast enhancement area in the intercostal muscle adjacent to the rib. <bold>C</bold>. FDG-PET/CT scan documenting two focuses of abnormal FDG uptake in the left hemithorax. <bold>D</bold>. Recurrence of squamous cell cervical carcinoma in the rib cage muscle. The bands of skeletal muscle are separated and infiltrated by nests of squamous carcinoma cells surrounded by desmoplasic stroma and showing areas of keratinisation. (Hematoxylin &amp; Eosin, magnification 100&#xD7;).</p>
        </caption>
        <graphic xlink:href="1471-2407-6-169-1"/>
      </fig>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Characteristics of cervical cancer patients with skeletal muscle involvement, as reported in the literature</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Author</bold>
              </td>
              <td align="center">
                <bold>Primary tumor histotype</bold>
              </td>
              <td align="center">
                <bold>Stage</bold>
              </td>
              <td align="center">
                <bold>Interval from primary tumor (months)</bold>
              </td>
              <td align="center">
                <bold>Skeletal muscle</bold>
              </td>
              <td align="center">
                <bold>HIV status</bold>
              </td>
              <td align="center">
                <bold>Treatment</bold>
              </td>
              <td align="center">
                <bold>Clinical outcome (after diagnosis of metastasis)</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Mariya [2]</td>
              <td align="center">squamous</td>
              <td align="center">n.a.</td>
              <td align="center">n.a.</td>
              <td align="center">Biceps</td>
              <td align="center">negative</td>
              <td align="center">n.a.</td>
              <td align="center">n.a.</td>
            </tr>
            <tr>
              <td align="left">Schwartz [3]</td>
              <td align="center">squamous</td>
              <td align="center">IIIB</td>
              <td align="center">0</td>
              <td align="center">Iliopsoas</td>
              <td align="center">positive</td>
              <td align="center">Chemotherapy followed by radiotherapy</td>
              <td align="center">DOD after 3 months</td>
            </tr>
            <tr>
              <td align="left">Singh [4]</td>
              <td align="center">squamous</td>
              <td align="center">IIIB</td>
              <td align="center">0</td>
              <td align="center">Psoas</td>
              <td align="center">positive</td>
              <td align="center">Patient declined</td>
              <td align="center">n.a.</td>
            </tr>
            <tr>
              <td align="left">Wong [5]</td>
              <td align="center">small cell</td>
              <td align="center">IB</td>
              <td align="center">24</td>
              <td align="center">Masseter</td>
              <td align="center">negative</td>
              <td align="center">Chemotherapy + radiotherapy</td>
              <td align="center">n.a.</td>
            </tr>
            <tr>
              <td align="left">Bar Dayan [6]</td>
              <td align="center">squamous</td>
              <td align="center">IIIB</td>
              <td align="center">0</td>
              <td align="center">Psoas</td>
              <td align="center">negative</td>
              <td align="center">Intralesional chemotherapy followed by radiotherapy</td>
              <td align="center">DOD after 4 months</td>
            </tr>
            <tr>
              <td align="left">Pathy [7]</td>
              <td align="center">squamous</td>
              <td align="center">IIIB</td>
              <td align="center">0</td>
              <td align="center">Deltoid</td>
              <td align="center">negative</td>
              <td align="center">Palliative radiotherapy</td>
              <td align="center">ED at time of publication</td>
            </tr>
            <tr>
              <td align="left">Devendra [8]</td>
              <td align="center">squamous</td>
              <td align="center">n.a.</td>
              <td align="center">0</td>
              <td align="center">Psoas</td>
              <td align="center">negative</td>
              <td align="center">Supportive therapy</td>
              <td align="center">Lost to follow up</td>
            </tr>
            <tr>
              <td align="left">Saadi [9]</td>
              <td align="center">squamous</td>
              <td align="center">IIB</td>
              <td align="center">60</td>
              <td align="center">Psoas</td>
              <td align="center">negative</td>
              <td align="center">Metastasectomy, radiotherapy</td>
              <td align="center">NED after 30 months</td>
            </tr>
            <tr>
              <td align="left">Current case</td>
              <td align="center">squamous</td>
              <td align="center">IB</td>
              <td align="center">76</td>
              <td align="center">Intercostal</td>
              <td align="center">negative</td>
              <td align="center">Metastasectomy followed by chemotherapy + radiotherapy</td>
              <td align="center">NED after 8 months</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>n.a. = not available; DOD = death of disease; ED = alive with evidence of disease; NED = no evidence of disease</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
  </back>
</article>
</pmc-articleset>
